跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
左代 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Brivudine Tablets
Approved
化学药品
Brivudine Tablets
BERLIN-CHEMIE AG
🇨🇳 National Medical Products Administration
Approval Date
Mar 26, 2020
Approval ID
7MazXbAXdMT
Company
BERLIN-CHEMIE AG
Type
化学药品
Approval Details
Approval Id
7MazXbAXdMT
Approval Number
H20140208
Generic Name
溴夫定片
Generic Name En
Brivudine Tablets
Trade Name
左代
Brand Name
左代
Drug Type
化学药品
Dosage Form
片剂
Strength
125mg
Reg Date
2020-03-26
Expired Date
2025-03-25
Company Name
BERLIN-CHEMIE AG
Company Address
Glienicker Weg 125, 12489 Berlin, Federal Republic of Germany
Production Company Name
BERLIN-CHEMIE AG
Production Company Address
Tempelhofer Weg 83, 12347 Berlin, Federal Republic of Germany
Company Detail Path
/organization/berlin-chemie-ag
Production Company Detail Path
/organization/berlin-chemie-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 26, 2020
Approval ID
7MazXbAXdMT
Type
化学药品
Back to NMPA Approvals